Page last updated: 2024-10-29

imipramine and Myxedema

imipramine has been researched along with Myxedema in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Myxedema: A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MCGRATH, MD1
PALEY, RG1

Other Studies

1 other study available for imipramine and Myxedema

ArticleYear
Hypothermia induced in a myxoedematous patient by imipramine hydrochloride.
    British medical journal, 1960, Nov-05, Volume: 2, Issue:5209

    Topics: Humans; Hypothermia; Imipramine; Myxedema; Psychopharmacology

1960